241 related articles for article (PubMed ID: 28577652)
1. Splenic marginal zone lymphoma: a literature review of diagnostic and therapeutic challenges.
Santos TSD; Tavares RS; Farias DLC
Rev Bras Hematol Hemoter; 2017; 39(2):146-154. PubMed ID: 28577652
[TBL] [Abstract][Full Text] [Related]
2. [Progress on Treatment of Splenic Marginal Zone Lymphoma-Review].
Wu L; Tian C; Zhang YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):600-603. PubMed ID: 28446319
[TBL] [Abstract][Full Text] [Related]
3. [Splenic marginal zone lymphoma].
Mohamed S
Pan Afr Med J; 2017; 26():111. PubMed ID: 28533834
[TBL] [Abstract][Full Text] [Related]
4. Treatment of splenic marginal zone lymphoma.
Kalpadakis C; Pangalis GA; Angelopoulou MK; Vassilakopoulos TP
Best Pract Res Clin Haematol; 2017; 30(1-2):139-148. PubMed ID: 28288709
[TBL] [Abstract][Full Text] [Related]
5. Optimal Rituximab Monotherapy in Splenic Marginal Zone Lymphoma (SMZL): A Case Report and Brief Review.
Guan RY; Tang XR; Huang ZF; Du J; Fu XH; Lu G; Mou WW
Recent Pat Anticancer Drug Discov; 2023 Nov; ():. PubMed ID: 37937574
[TBL] [Abstract][Full Text] [Related]
6. Should rituximab replace splenectomy in the management of splenic marginal zone lymphoma?
Kalpadakis C; Pangalis GA; Angelopoulou MK; Sachanas S; Vassilakopoulos TP
Best Pract Res Clin Haematol; 2018 Mar; 31(1):65-72. PubMed ID: 29452668
[TBL] [Abstract][Full Text] [Related]
7. Splenic lymphoma with circulating villous lymphocytes/splenic marginal-zone lymphoma.
Catovsky D; Matutes E
Semin Hematol; 1999 Apr; 36(2):148-54. PubMed ID: 10319383
[TBL] [Abstract][Full Text] [Related]
8. Treatment of splenic marginal zone lymphoma: should splenectomy be abandoned?
Kalpadakis C; Pangalis GA; Vassilakopoulos TP; Sachanas S; Angelopoulou MK
Leuk Lymphoma; 2014 Jul; 55(7):1463-70. PubMed ID: 24050506
[TBL] [Abstract][Full Text] [Related]
9. Splenic marginal zone lymphoma.
Franco V; Florena AM; Iannitto E
Blood; 2003 Apr; 101(7):2464-72. PubMed ID: 12446449
[TBL] [Abstract][Full Text] [Related]
10. Splenic marginal zone lymphoma: a case report and literature review.
Zhang S; Xuan Z; Zhang L; Lu J; Song P; Zheng S
World J Surg Oncol; 2020 Oct; 18(1):259. PubMed ID: 33004051
[TBL] [Abstract][Full Text] [Related]
11. A marginal zone pattern may be found in different varieties of non-Hodgkin's lymphoma: the morphology and immunohistology of splenic involvement by B-cell lymphomas simulating splenic marginal zone lymphoma.
Piris MA; Mollejo M; Campo E; Menárguez J; Flores T; Isaacson PG
Histopathology; 1998 Sep; 33(3):230-9. PubMed ID: 9777389
[TBL] [Abstract][Full Text] [Related]
12. Significant efficacy of 2-chlorodeoxyadenosine{+/-} rituximab in the treatment of splenic marginal zone lymphoma (SMZL): extended follow-up.
Cervetti G; Galimberti S; Pelosini M; Ghio F; Cecconi N; Petrini M
Ann Oncol; 2013 Sep; 24(9):2434-8. PubMed ID: 23712547
[TBL] [Abstract][Full Text] [Related]
13. Marginal zone-related neoplasms of splenic and nodal origin.
Arcaini L; Paulli M; Boveri E; Magrini U; Lazzarino M
Haematologica; 2003 Jan; 88(1):80-93. PubMed ID: 12551831
[TBL] [Abstract][Full Text] [Related]
14. Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era.
Perrone S; D'Elia GM; Annechini G; Ferretti A; Tosti ME; Foà R; Pulsoni A
Leuk Res; 2016 May; 44():53-60. PubMed ID: 27030961
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study.
Iannitto E; Bellei M; Amorim S; Ferreri AJM; Marcheselli L; Cesaretti M; Haioun C; Mancuso S; Bouabdallah K; Gressin R; Tripodo C; Traverse-Glehen A; Baseggio L; Zupo S; Stelitano C; Castagnari B; Patti C; Alvarez I; Liberati AM; Merli M; Gini G; Cabras MG; Dupuis J; Tessoulin B; Perrot A; Re F; Palombi F; Gulino A; Zucca E; Federico M; Thieblemont C
Br J Haematol; 2018 Dec; 183(5):755-765. PubMed ID: 30407629
[TBL] [Abstract][Full Text] [Related]
16. Composite splenic marginal zone lymphoma and classic Hodgkin lymphoma -- an unusual combination.
Elmahy H; Hawley I; Beard J
Int J Lab Hematol; 2007 Dec; 29(6):461-3. PubMed ID: 17988302
[TBL] [Abstract][Full Text] [Related]
17. Splenic marginal zone lymphoma.
Piris MA; Onaindía A; Mollejo M
Best Pract Res Clin Haematol; 2017; 30(1-2):56-64. PubMed ID: 28288718
[TBL] [Abstract][Full Text] [Related]
18. Incidental Splenic Marginal Zone Lymphoma With Extreme Macrocytosis After Hydroxyurea Use: A Case Report.
Sultan K; Kal S; Wasson A; Farmand F
Cureus; 2023 Jan; 15(1):e33462. PubMed ID: 36751210
[TBL] [Abstract][Full Text] [Related]
19. Splenectomy in Lymphoproliferative Disorders: A Single Eastern European Center Experience.
Onisâi M; Vlădăreanu AM; Nica A; Spînu A; Găman M; Bumbea H; Voican I; Iordan I; Alexandru A; Zdrenghea M; Gheorghita D; Grădinaru S
Medicina (Kaunas); 2019 Dec; 56(1):. PubMed ID: 31892196
[No Abstract] [Full Text] [Related]
20. Nodal and splenic marginal zone B cell lymphomas.
Mollejo M; Camacho FI; Algara P; Ruiz-Ballesteros E; García JF; Piris MA
Hematol Oncol; 2005; 23(3-4):108-18. PubMed ID: 16307458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]